Integer Holdings (ITGR) Income from Discontinued Operations (2017 - 2025)
Integer Holdings' (ITGR) quarterly Income from Discontinued Operations came in at -$22000.0 in Q1 2025, up 73.49% year-over-year from -$12680.6 in Q1 2024, and up 91.85% quarter-over-quarter from -$270000.0 in Q4 2024.
Powered by 
Analysis
Integer Holdings (ITGR) Income from Discontinued Operations (2017 - 2025) Analysis & Trends
Integer Holdings has disclosed Income from Discontinued Operations across 6 years of filings, most recently posting -$22000.0 for Q1 2025.
- In Q1 2025, Income from Discontinued Operations rose 73.49% year-over-year to -$22000.0; the TTM figure through Dec 2025 stood at -$22000.0 (up 98.1% YoY), while the FY2025 annual figure was -$22000.0, up 98.1% from the prior year.
- Income from Discontinued Operations came in at -$22000.0 for Q1 2025 at Integer Holdings, up from -$270000.0 in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $39000.0 in Q2 2024 to a low of -$917000.0 in Q3 2023.
- Average Income from Discontinued Operations over 3 years is -$364571.4, with a median of -$270000.0 recorded in 2024.
- Year-over-year, Income from Discontinued Operations grew 8.07% in 2024 and soared 73.49% in 2025.
- Over 3 years, Income from Discontinued Operations stood at -$456000.0 in 2023, then surged by 40.79% to -$270000.0 in 2024, then surged by 91.85% to -$22000.0 in 2025.
- Per Business Quant data, the three most recent Income from Discontinued Operations figures were -$22000.0 in Q1 2025, -$270000.0 in Q4 2024, and -$843000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Integer Holdings | 4.29 Bn | 4.27 Bn | 112.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 28, 2025 | -22,000.00 |
| Dec 31, 2024 | -270,000.00 |
| Sep 27, 2024 | -843,000.00 |
| Jun 28, 2024 | 39,000.00 |
| Mar 29, 2024 | -83,000.00 |
| Dec 31, 2023 | -456,000.00 |
| Sep 29, 2023 | -917,000.00 |
| Dec 31, 2019 | -20,000.00 |
| Jun 28, 2019 | 4.93 Mn |
| Mar 29, 2019 | 386,000.00 |
| Dec 28, 2018 | 62,000.00 |
| Sep 28, 2018 | 195.87 Mn |
| Jun 29, 2018 | -3.03 Mn |
| Mar 30, 2018 | -6.25 Mn |
| Dec 29, 2017 | -6.36 Mn |
| Sep 29, 2017 | -7.44 Mn |
| Jun 30, 2017 | -6.57 Mn |